This panel details liabilities and risks applicable to nanotechnology under the US legal system and reviews available insurance coverage and risk management and risk transfer strategies. Panelists also explore the insurance industry’s view of nanotechnology risk and offer historically informed insights into likely insurance market reactions to emerging risks. Panelists include:
- Sallie Krause, Ernst & Young LLP
- Mark Silvestri, CNA Corporation
Click the link below for complete program information.